SCHEMBL13638562

SCHEMBL13638562

C=C1CC(Nc2nccc(-c3ccc(S(N)(=O)=O)s3)n2)CC(C)(C)N1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.39
DKK1 O94907 1/20 0.39
GSK3B P49841 1/20 0.39
CCNA2 P20248 4/20 0.36
CDK2 P24941 4/20 0.36
CDK1 P06493 3/20 0.36
CCNB1 P14635 3/20 0.36
CCNA1 P78396 3/20 0.36
CCNT1 O60563 2/20 0.36
CDK7 P50613 2/20 0.36
CDK9 P50750 2/20 0.36
CCNH P51946 2/20 0.36
CA12 O43570 4/20 0.34
CA1 P00915 4/20 0.34
CA2 P00918 4/20 0.34
CA9 Q16790 4/20 0.34
MAPK8 P45983 3/20 0.34
MAPK9 P45984 2/20 0.34
MAPK10 P53779 2/20 0.34
CHUK O15111 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13638518 0.98 IKBKB (0.38) IKBKBDKK1GSK3BCCNA2CDK2
SCHEMBL14612876 0.87 IKBKB (0.45) IKBKBDKK1GSK3BCCNA2CDK2
SCHEMBL3472506 0.86 IKBKB (0.43) IKBKBDKK1GSK3BCCNA2CDK2
SCHEMBL4500382 0.84 IKBKB (0.41) IKBKBDKK1GSK3BCCNA2CDK2
SCHEMBL13638454 0.83 CDK4 (0.36) IKBKBGSK3BCCNA2CDK2CDK1
SCHEMBL14612785 0.83 IKBKB (0.37) IKBKBGSK3BCCNA2CDK2CDK1
SCHEMBL13638478 0.83 IKBKB (0.48) IKBKBCDK2MAPK8MAPK9MAPK10
SCHEMBL13638672 0.82 CDK1 (0.40) IKBKBGSK3BCCNA2CDK2CDK1
SCHEMBL13638295 0.82 AKT3 (0.38) GSK3BCCNA2CDK2CDK1CCNB1
SCHEMBL13638429 0.82 IKBKB (0.34) IKBKBGSK3BCCNA2CDK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed